NGL Fine Chem Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.14 | 0.14 | 0.13 | 0.17 | 0.29 |
Long Term Debt-Equity Ratio | 0.01 | 0.01 | 0.03 | 0.06 | 0.08 |
Current Ratio | 1.87 | 2.11 | 2.21 | 1.94 | 1.68 |
Fixed Assets | 3.15 | 2.86 | 3.60 | 3.11 | 1.96 |
Inventory | 9.46 | 6.70 | 6.86 | 7.85 | 6.54 |
Debtors | 4.44 | 4.23 | 6.22 | 8.10 | 5.13 |
Interest Cover Ratio | 29.17 | 15.54 | 37.12 | 35.55 | 7.33 |
PBIDTM (%) | 18.44 | 13.21 | 24.65 | 33.15 | 17.40 |
PBITM (%) | 15.96 | 10.34 | 22.25 | 30.29 | 12.62 |
PBDTM (%) | 17.89 | 12.54 | 24.05 | 32.30 | 15.68 |
CPM (%) | 14.19 | 10.19 | 18.80 | 24.35 | 12.72 |
APATM (%) | 11.71 | 7.32 | 16.40 | 21.49 | 7.94 |
ROCE (%) | 18.73 | 11.37 | 34.27 | 51.07 | 15.21 |
RONW (%) | 15.78 | 9.31 | 28.87 | 43.22 | 12.51 |